Cargando…

Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes

Mounting evidence suggested that the gut microbiota has a significant role in the metabolism and disease status of the host. In particular, Type 2 Diabetes (T2D), which has a complex etiology that includes obesity and chronic low-grade inflammation, is modulated by the gut microbiota and microbial m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huda, M. Nazmul, Kim, Myungsuk, Bennett, Brian J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060771/ https://www.ncbi.nlm.nih.gov/pubmed/33897618 http://dx.doi.org/10.3389/fendo.2021.632335

Ejemplares similares

Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model
por: Yang, Mei, et al.
Publicado: (2020)

Distribution characteristics of oral microbiota and its relationship with intestinal microbiota in patients with type 2 diabetes mellitus
por: Guo, Xiao-jing, et al.
Publicado: (2023)

Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
por: Wu, Jiaqiang, et al.
Publicado: (2023)

Therapeutic Potential of Butyrate for Treatment of Type 2 Diabetes
por: Arora, Tulika, et al.
Publicado: (2021)

Integrative analysis of hepatic transcriptional profiles reveals genetic regulation of atherosclerosis in hyperlipidemic Diversity Outbred-F1 mice
por: Kim, Myungsuk, et al.
Publicado: (2023)

The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis
por: Xu, Yunxi, et al.
Publicado: (2022)

Correlation Between Gut Microbiota and Testosterone in Male Patients With Type 2 Diabetes Mellitus
por: Liu, Shuang, et al.
Publicado: (2022)

Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
por: He, Qiongyao, et al.
Publicado: (2022)

Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
por: Huang, Yuxin, et al.
Publicado: (2022)

Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus
por: Wang, Limin, et al.
Publicado: (2023)

Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule
por: Christen, Urs, et al.
Publicado: (2020)

The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
por: Dedrick, Sandra, et al.
Publicado: (2020)

Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells
por: Jo, Sugyeong, et al.
Publicado: (2021)

Probiotic induced synthesis of microbiota polyamine as a nutraceutical for metabolic syndrome and obesity-related type 2 diabetes
por: Bui, Tina I., et al.
Publicado: (2023)

FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
por: Teaney, Nicole A., et al.
Publicado: (2023)

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
por: Hou, Xintong, et al.
Publicado: (2022)

Benefits of Huang Lian mediated by gut microbiota on HFD/STZ-induced type 2 diabetes mellitus in mice
por: Li, Dan, et al.
Publicado: (2023)

Effect of “maccog” TCM tea on improving glucolipid metabolism and gut microbiota in patients with type 2 diabetes in community
por: Hu, Biyue, et al.
Publicado: (2023)

The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
por: Zhang, Lin, et al.
Publicado: (2022)

Dysbiosis signatures of gut microbiota and the progression of type 2 diabetes: a machine learning approach in a Mexican cohort
por: Neri-Rosario, Daniel, et al.
Publicado: (2023)

Editorial: Understanding the role of gut hormones, microbiota, and miRNAs in metabolic regulation and glucose homeostasis in obesity and type-2-diabetes
por: Matz, Lisa M., et al.
Publicado: (2023)

Neuropsychological Outcomes in Individuals With Type 1 and Type 2 Diabetes
por: Putnam, Nathaniel M., et al.
Publicado: (2022)

A network perspective on the ecology of gut microbiota and progression of type 2 diabetes: Linkages to keystone taxa in a Mexican cohort
por: Esquivel-Hernández, Diego A., et al.
Publicado: (2023)

Integrating Choline and Specific Intestinal Microbiota to Classify Type 2 Diabetes in Adults: A Machine Learning Based Metagenomics Study
por: Zeng, Qiang, et al.
Publicado: (2022)

Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes
por: Chen, Rong-Bin, et al.
Publicado: (2023)

Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms
por: Zhou, He, et al.
Publicado: (2020)

Urocortin 3 Levels Are Impaired in Overweight Humans With and Without Type 2 Diabetes and Modulated by Exercise
por: Kavalakatt, Sina, et al.
Publicado: (2019)

Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health
por: Huda, M. Nazmul, et al.
Publicado: (2022)

New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
por: Zhang, Mengdi, et al.
Publicado: (2022)

Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus
por: Song, Jinfang, et al.
Publicado: (2022)

Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications
por: Li, Xiang, et al.
Publicado: (2022)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

FGM-based remote intervention for adults with type 1 diabetes: The FRIEND randomized clinical trial
por: Lee, Jinju, et al.
Publicado: (2022)

The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions
por: Zhang, Miao, et al.
Publicado: (2022)

P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes?
por: Mesto, Nour, et al.
Publicado: (2022)

Influence of Maternal Inulin-Type Prebiotic Intervention on Glucose Metabolism and Gut Microbiota in the Offspring of C57BL Mice
por: Zhang, Qian, et al.
Publicado: (2019)

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
por: Ding, Jia-Tong, et al.
Publicado: (2023)

New therapeutic directions in type II diabetes and its complications: mitochondrial dynamics
por: Wang, Shengnan, et al.
Publicado: (2023)

Community-Based Physical Activity Interventions for Treatment of Type 2 Diabetes: A Systematic Review with Meta-Analysis
por: Plotnikoff, Ronald C., et al.
Publicado: (2013)

Gastrointestinal Helminth Infection Improves Insulin Sensitivity, Decreases Systemic Inflammation, and Alters the Composition of Gut Microbiota in Distinct Mouse Models of Type 2 Diabetes
por: Khudhair, Zainab, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gc254bsde0l66cv9128s5uviq5